NEAT ID Foundation
- Address
- Hoogstraat 322, Pl 709
Sponsor Overview
Specializations
HIV-1 Treatment Optimisation
The NEAT ID Foundation supports clinical research focused on therapeutic strategies for people living with HIV-1, with particular attention to treatment adjustment and regimen performance in complex care settings.
- Antiretroviral therapy
- Treatment switch strategies
- Viral suppression
Its funded studies include evaluation of regimen changes for patients with limited therapeutic options and assessment of outcomes linked to maintaining HIV viral load control.
Advanced HIV Infection
Clinical activity also centres on advanced HIV infection, including patients who present late during acquisition of the virus and require careful optimisation of treatment choices.
- Late presentation
- Therapeutic resistance
- Complex patient management
Research in this area addresses the needs of individuals with advanced disease and limited options for sustained antiretroviral control.
Integrase Inhibitor and Protease Inhibitor Regimens
The sponsor has a clear interest in comparing integrase inhibitor-based regimens with boosted protease inhibitor treatments in people with advanced HIV disease.
- Regimen comparison
- Therapeutic equivalence
- Virologic outcomes
This includes studies examining whether one treatment approach offers improved control or maintains non-inferior outcomes in challenging clinical settings.
Patient-Focused HIV Care
As a patient organisation, the foundation is involved in research addressing real-world treatment needs for people living with HIV, especially those with restricted therapeutic choices.
- Limited therapeutic options
- Switching therapy
- Clinical outcome monitoring
Its trial portfolio spans multiple collaborating sites across several European countries, reflecting interest in specialist HIV care delivery.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Assessment of Efficacy and Safety of Switching from Boosted Protease Inhibitor to Fostemsavir Trometamol in HIV-1 Patients with Limited Therapeutic Options |  Italy Spain | Not Recruiting |
| Comparative Study of Integrase Inhibitor Regimen Versus Boosted Protease Inhibitor Regimen in Late-Presenting Advanced HIV-1 Patients |  Belgium France Germany Ireland Italy Spain | Not Recruiting |
Data & Insights
This sponsor works with 6 molecules, of which 1 is not being studied by other sponsors.
This sponsor has worked with 36 sites across their trial portfolio.
Therapeutic Focus
- 1.Virus Diseases2 trials182 other sponsors
Partnered Research Centres
36 centres- Address
- Num Voie 47 A 83, 47 Boulevard De L Hopital, 75013 Paris
- Address
- Via Giovanni Battista Grassi 74, 20157 Milan
- Address
- Via Nicolo' Giustiniani 2, 35128 Padua
- Address
- Corso Svizzera 164, 10149 Turin
- Address
- Via Antonio Di Rudini' 8, 20142 Milan
- Address
- Carrer De La Feixa Llarga S/N, 08907 L'hospitalet De Llobregat
Want to get in touch with this sponsor?
Send a question and we'll pass it on to NEAT ID Foundation.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.